Clinical Significance of sIL-2R Levels in B-Cell Lymphomas

• Noriaki Yoshida ,

  * E-mail: nyoshida@aichi-cc.jp (NY); sakira@fmu.ac.jp (AS)

  Affiliations Department of Hematology and Oncology, Research Institute Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan, Department of Cancer Genetics, Nagoya University Graduate School of Medicine at Aichi Cancer Center Research Institute, Nagoya, Japan

  ⨯
• Miyo Oda,

  Affiliation Department of Anatomical Pathology, Hiroshima University, Hiroshima, Japan

  ⨯
• Yoshiaki Kuroda,

  Affiliation Department of Hematology and Oncology, Research Institute Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

  ⨯
• Yuta Katayama,

  Affiliation Department of Internal Medicine, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan

  ⨯
• Yoshiko Okikawa,

  Affiliation Department of Hematology, National Hospital Organization Kure Medical Center, Kure, Japan

  ⨯
• Taro Masunari,

  Affiliation Department of Hematology, Chugoku Central Hospital, Fukuyama, Japan

  ⨯
• Megumu Fujiwara,

  Affiliation Department of Pathology, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan

  ⨯
• Takashi Nishisaka,

  Affiliation Department of Laboratory Pathology, Hiroshima Prefecture Hospital, Hiroshima, Japan

  ⨯
• Naomi Sasaki,

  Affiliation Department of Pathology, Kure Kyosai Hospital, Kure, Japan

  ⨯
• Yoshito Sadahira,

  Affiliation Department of Pathology, Kawasaki Medical School, Kurashiki, Japan

  ⨯
• Keichiro Mihara,

  Affiliation Department of Hematology and Oncology, Research Institute Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

  ⨯
• Hideki Asaoku,

  Affiliation Department of Internal Medicine, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan

  ⨯
• Hirotaka Matsui,

  Affiliation Department of Molecular Oncology & Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

  ⨯
• Masao Seto,

  Affiliations Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan, Department of Cancer Genetics, Nagoya University Graduate School of Medicine at Aichi Cancer Center Research Institute, Nagoya, Japan

  ⨯
• Akiro Kimura,

  Affiliations Department of Hematology and Oncology, Research Institute Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, Department of Laboratory medicine, Kure Kyosai Hospital, Kure, Japan

  ⨯
• Koji Arihiro,

  Affiliation Department of Anatomical Pathology, Hiroshima University, Hiroshima, Japan

  ⨯
•  [ ... ],
• Akira Sakai

  * E-mail: nyoshida@aichi-cc.jp (NY); sakira@fmu.ac.jp (AS)

  Affiliations Department of Hematology and Oncology, Research Institute Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, Department of Radiation Life Science, Fukushima Medical University, Fukushima, Japan

  ⨯
• [ view all ]
• [ view less ]